133 related articles for article (PubMed ID: 14667759)
1. The EUROPA trial.
Brophy JM
Lancet; 2003 Dec; 362(9399):1936; author reply 1936-7. PubMed ID: 14667759
[No Abstract] [Full Text] [Related]
2. [ACE-inhibitor effects on the stabilization of coronary heart disease. EUROPA study].
Böhm M
Internist (Berl); 2004 Oct; 45(10):1196-8. PubMed ID: 15372169
[No Abstract] [Full Text] [Related]
3. Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland: an analysis of the EUROPA study including 1251 Polish patients.
Redekop WK; Orlewska E; Maciejewski P; Rutten FF; Niessen LW
Pharmacoeconomics; 2008; 26(10):861-77. PubMed ID: 18793033
[TBL] [Abstract][Full Text] [Related]
4. PERSUADE...(a EUROPA sub-study)...results: perindopril protects diabetic patients with coronary disease from cardiovascular death and heart attacks.
Cardiovasc J S Afr; 2004; 15(3):146. PubMed ID: 15356914
[No Abstract] [Full Text] [Related]
5. Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.
Briggs A; Mihaylova B; Sculpher M; Hall A; Wolstenholme J; Simoons M; Deckers J; Ferrari R; Remme WJ; Bertrand M; Fox K;
Heart; 2007 Sep; 93(9):1081-6. PubMed ID: 17135223
[TBL] [Abstract][Full Text] [Related]
6. Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
White HD
Lancet; 2003 Sep; 362(9386):755-7. PubMed ID: 13678865
[No Abstract] [Full Text] [Related]
7. The EUROPA trial.
Stoschitzky K
Lancet; 2003 Dec; 362(9399):1935-6; author reply 1936-7. PubMed ID: 14667757
[No Abstract] [Full Text] [Related]
8. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
[TBL] [Abstract][Full Text] [Related]
9. The EUROPA trial.
Boos C
Lancet; 2003 Dec; 362(9399):1935; author reply 1936-7. PubMed ID: 14667756
[No Abstract] [Full Text] [Related]
10. The EUROPA trial.
Kwaku M; Burman KD; Becker KL; Mannan M
Lancet; 2003 Dec; 362(9399):1935; author reply 1936-7. PubMed ID: 14667758
[No Abstract] [Full Text] [Related]
11. Combine EUROPA and HOPE.
Fuller JA
Lancet; 2003 Dec; 362(9399):1937. PubMed ID: 14667761
[No Abstract] [Full Text] [Related]
12. ACE inhibitors: the impact of the EUROPA study on CAD.
Cardiovasc J S Afr; 2003; 14(4):211-2. PubMed ID: 14619870
[No Abstract] [Full Text] [Related]
13. EUROPA: clinical benefits, clinical promise.
Cardiovasc J S Afr; 2004; 15(3):147. PubMed ID: 15356915
[No Abstract] [Full Text] [Related]
14. Perindopril protects diabetics with coronary disease from cardiovascular death and heart attacks.
Cardiovasc J S Afr; 2004; 15(2):98. PubMed ID: 15148549
[No Abstract] [Full Text] [Related]
15. Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.
Oemrawsingh RM; Akkerhuis KM; Van Vark LC; Redekop WK; Rudez G; Remme WJ; Bertrand ME; Fox KM; Ferrari R; Danser AH; de Maat M; Simoons ML; Brugts JJ; Boersma E;
J Am Heart Assoc; 2016 Mar; 5(3):e002688. PubMed ID: 27021566
[TBL] [Abstract][Full Text] [Related]
16. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
Bertrand ME; Remme WJ; Fox KM; Ferrari R; Simoons ML;
Int J Cardiol; 2007 Sep; 121(1):57-61. PubMed ID: 17270296
[TBL] [Abstract][Full Text] [Related]
17. The EUROPA trial: design, baseline demography and status of the substudies.
Gomma AH; Fox KM
Cardiovasc Drugs Ther; 2001 Mar; 15(2):169-79. PubMed ID: 11669411
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).
Fox KM;
Lancet; 2003 Sep; 362(9386):782-8. PubMed ID: 13678872
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial.
Bertrand ME; Fox KM; Remme WJ; Ferrari R; Simoons ML
Arch Cardiovasc Dis; 2009 Feb; 102(2):89-96. PubMed ID: 19303575
[TBL] [Abstract][Full Text] [Related]
20. New pathophysiological insights explain life-saving benefits of perindopril in coronary artery disease patients.
Cardiovasc J S Afr; 2004; 15(5):248-9. PubMed ID: 15483736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
